Massachusetts Institute of Technology: Risk Assessment for Nanomaterials: Current Developments and Trends

Download IconDownload Print IconPrint

Massachusetts Institute of Technology: Risk Assessment for Nanomaterials: Current Developments and Trends

Speaking Engagement
This full day Continuing Education Course, sponsored by the Cambridge Health Department, Massachusetts Toxics Use Reduction Institute, Cambridge Health Alliance, Massachusetts Institute of Technology, and the NSF Center for High Rate Nanomanufacturing, covered a diverse range of topics essential for professionals in nanotechnology and biotechnology. Attendees were able to learn about a variety of topics, including the current understanding of nanomaterial risks, EHS state-of-the-practice in companies involved with nanomaterials, current and anticipated regulatory developments in the field, a primer on the toxicology of nanomaterials and an assessment of appropriate occupational safety and health practices associated with these technologies.

WilmerHale Counsel James Votaw was a featured speaker at this event. He spoke on the topic of "Regulation of Nanomaterials: Developments and Trends at US EPA.”

Read More About the Event

You May Be Interested In

The 7th Annual Black Blockchain Summit

September 21, 2024
Speaking Engagement

SIFMA C & L Regional Seminar: Charlotte

September 23, 2024
Speaking Engagement

The European Union’s Artificial Intelligence Act: What Do You Need to Know if You Want to Use AI?

September 24, 2024
Webinar
View all Events

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel